Showing 317 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Side effects

TAF only superior to TDF when used with a boosting agent

News
10 April 2018
Drug interactions & pharmacokinetics

Twice-daily dolutegravir is safe and effective when used alongside TB treatment

News
7 March 2018
Tuberculosis & HIV

Dolutegravir and Rifapentine study stopped due to serious toxicities

Editor's pick
Medical Brief
1 March 2018
Ageing & HIV

Taking multiple Rx drugs raises risks for aging adults with and without HIV

Editor's pick
Yale News
1 February 2018
Injectable & long-acting HIV treatment

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

News
9 January 2018
PrEP science

Experts concur that event-related oral PrEP probably won’t work for women

News
1 September 2017
Drug interactions & pharmacokinetics

Trans women wary of antiretroviral drug and hormone interactions

News
23 August 2017
Transgender people

Drug interaction concerns may negatively affect HIV treatment adherence among transgender women

Editor's pick
NIAID
25 July 2017
Contraception

Taking Birth Control With HIV Treatment or PrEP Is Largely OK

Editor's pick
Poz
30 May 2017
Generic medicines

Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

Editor's pick
HIV i-Base
23 May 2017
Hepatitis & HIV

Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals

News
10 March 2017
New & experimental HIV treatments

New nano approach could cut dose of leading HIV treatment in half

Editor's pick
University of Liverpool press release
21 February 2017
PrEP

Gates Foundation to Invest Up to $140 Million in HIV Prevention Device

Editor's pick
Wall Street Journal
30 December 2016
Government, leadership & policy

What's at Stake in Trump's America? HIV Community Leaders Share Their Opinions

Editor's pick
The Body
21 November 2016
PrEP science

The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

News
11 November 2016
PrEP science

Tests of online PrEP purchases by London clinic find no fakes, and adequate drug levels

News
26 October 2016
Side effects

Doctors in Netherlands observe higher than expected dolutegravir treatment discontinuation rate

News
13 October 2016
PrEP

Evidence that “on-demand” PrEP taken before and after sex can prevent HIV

Editor's pick
BETA blog
12 September 2016
Drug interactions & pharmacokinetics

University HIV smartphone app receives international award

Editor's pick
University of Liverpool press release
1 September 2016
Hepatitis C treatment

Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study

News
21 July 2016
Drug interactions & pharmacokinetics

Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals

News
14 March 2016
Transgender people

Transgender people are at high risk for HIV, but too little is known about prevention and treatment for this population

News
11 March 2016
PrEP

Women need more of the HIV drug Truvada than men to prevent infection

Editor's pick
Eurekalert Medicine & Health
4 March 2016
PrEP science

Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016

News
25 February 2016